SHH and neoplasm: Subsequent animal studies have achieved mixed results: while CSFR1 blockades decrease the degree of TAM infiltration regardless of the model used, therapeutic effects, including the attenuation of SHH MBL tumour progression and promotion of cytotoxic activity at the tumour site, have only been observed in primary tumours [119].